Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
12/06/2024 22:43
Aslan Pharmaceuticals Ltd 7A90y.BE :
* ASLAN PHARMACEUTICALS LTD FILES FOR SHELF OF UP TO 61.9
MILLION
ORDINARY SHARES BY SELLING STOCKHOLDER - SEC FILING
Source text for Eikon: ID:n0001193125-24-159983
Further company coverage: 7A90y.BE
Recent news on Aslan Pharmaceuticals
See all newsBrief: Aslan Pharmaceuticals Announces Plan To Implement ADS Ratio Change
Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
Brief: Aslan Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of Eblasakimab
Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln